Skip to main content
Contact Us
Subscribe
E-Edition
41°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quidelortho Corp
(NQ:
QDEL
)
37.89
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quidelortho Corp
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
December 20, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Participate in the Evercore ISI Conference
November 16, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report
November 16, 2023
QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm.
Via
Benzinga
Analyst Expectations for QuidelOrtho's Future
November 02, 2023
Via
Benzinga
Where QuidelOrtho Stands With Analysts
September 19, 2023
Via
Benzinga
QuidelOrtho's Return on Invested Capital Overview
May 11, 2023
Via
Benzinga
QuidelOrtho: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Why QuidelOrtho Stock Popped by 5% on Friday
April 15, 2023
It looks like the company's first quarter is going to please investors greatly.
Via
The Motley Fool
QuidelOrtho Reports Third Quarter 2023 Financial Results
November 01, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core Profitability: Analyst
October 12, 2023
QuidelOrtho Corporation (NASDAQ: QDEL) released preliminary Q3 revenue of $738 million to $744 million, primarily driven by higher respiratory product sales,
Via
Benzinga
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
October 12, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
September 21, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 28, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Analyst Is Frustrated By QuidelOrtho's Reduction In Guidance - Here's Why
August 15, 2023
Raymond James analyst Andrew Cooper reiterates Strong Buy on QuidelOrtho Corporation (NASDAQ: QDEL),
Via
Benzinga
QuidelOrtho Reports Second Quarter 2023 Financial Results
August 08, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
July 25, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
July 25, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Report Second Quarter 2023 Financial Results
July 18, 2023
From
QuidelOrtho Corporation
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
July 06, 2023
Via
Benzinga
Market Mixes It Up With A Broad Rally
June 05, 2023
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.
Via
Talk Markets
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
May 23, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Something Happened In Biotech Last Week
May 08, 2023
Biotech stocks were more constructive last week with some sharp moves up.
Via
Talk Markets
QuidelOrtho Reports First Quarter 2023 Financial Results
May 03, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
May 01, 2023
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
April 24, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 20, 2023
Via
Benzinga
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 14, 2023
Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.
Via
Benzinga
JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
April 14, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.